4/27
04:05 pm
gpcr
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
Low
Report
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
4/27
08:00 am
gpcr
Structure Therapeutics (GPCR) was given a new $101.00 price target by Canaccord Genuity Group Inc..
Medium
Report
Structure Therapeutics (GPCR) was given a new $101.00 price target by Canaccord Genuity Group Inc..
4/23
06:02 am
gpcr
Structure Therapeutics (GPCR) had its "sell (d-)" rating reaffirmed by
Weiss Ratings .
Low
Report
Structure Therapeutics (GPCR) had its "sell (d-)" rating reaffirmed by
Weiss Ratings .
4/18
11:43 am
gpcr
3 Ways to Invest in the Growing GLP-1 Weight Loss Market [Yahoo! Finance]
Medium
Report
3 Ways to Invest in the Growing GLP-1 Weight Loss Market [Yahoo! Finance]
4/18
01:00 am
gpcr
Medium
Report
4/14
04:18 pm
gpcr
Structure Therapeutics appoints Matthew Lang as chief operating officer [Seeking Alpha]
Low
Report
Structure Therapeutics appoints Matthew Lang as chief operating officer [Seeking Alpha]
4/14
04:05 pm
gpcr
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
Low
Report
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
4/8
04:16 pm
gpcr
Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat [Seeking Alpha]
Low
Report
Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat [Seeking Alpha]
4/23
06:56 pm
gpcr
Form 3 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
Medium
Report
Form 3 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
4/23
06:56 pm
gpcr
Form 4 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
Medium
Report
Form 4 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
4/23
06:56 pm
gpcr
Form DEF 14A Structure Therapeutics For: Jun 17
Medium
Report
Form DEF 14A Structure Therapeutics For: Jun 17
4/23
06:56 pm
gpcr
Form ARS Structure Therapeutics For: Dec 31
Medium
Report
Form ARS Structure Therapeutics For: Dec 31
4/16
02:17 pm
gpcr
Form 4 Structure Therapeutics For: Apr 14 Filed by: FMR LLC
Low
Report
Form 4 Structure Therapeutics For: Apr 14 Filed by: FMR LLC
4/15
06:08 am
gpcr
Form 8-K Structure Therapeutics For: Apr 15
Low
Report
Form 8-K Structure Therapeutics For: Apr 15
3/23
04:31 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Hall Ashley
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Hall Ashley
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Coll Crespo Blas
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Coll Crespo Blas
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register